S. Scott Lloyd, Member

Background hero atmospheric image for Lloyd, S. Scott
  • I believe that if you show people the problems and you show them the solutions they will be moved to act.

    -Bill Gates

    Scott is a Certified Licensing Professional (2023), which is an industry certification demonstrating experience and proficiency in the licensing and commercialization of intellectual property.




Scott Lloyd has more than fifteen years of experience in the intellectual property and technology space, including over a decade working as in-house general counsel before moving into private practice. Through this experience Scott has become a business-minded attorney who thrives on helping companies develop attractive intellectual property strategies and finding creative ways to overcome business obstacles for companies who rely on intellectual property protections and regulatory approvals to optimize business performance. Scott understands the demands of in-house legal counsel and therefore responds to clients’ needs efficiently and effectively, acting as external general counsel for many clients.

Scott’s industry experience includes biopharma, medical devices, software and agriculture, among others, in particular with emerging markets. Scott’s practice focus includes intellectual property counseling, prosecution and maintenance, data privacy and security, corporate and business transactions, and representation of clients before regulatory agencies such as the U.S. Food and Drug Administration (FDA), Environmental Protection Agency (EPA), and Customs and Border Protection (CBP).

Scott is a Certified Licensing Professional (2023), which is an industry certification demonstrating experience and proficiency in the licensing and commercialization of intellectual property.

Prior to joining Gordon Feinblatt, Scott worked at another Maryland law firm within its intellectual property practice group. In his spare time, Scott enjoys tennis, music and play by play announcing for the Rockville Rams high school football team.


Professional and Civic Involvement

Member, Maryland State Bar Association (MSBA), Intellectual Property Section

Member, International Association of Privacy Professionals (IAPP)

Economic Reviewer, Maryland Industrial Partnerships Program

Mentor, Venture Mentoring Services (VMS)

Greater Rockville Chamber of Commerce

Publications and Lectures


Presenter, "Software Patenting: What You Need to Know and Do Amid the Pandemic," The KnowledgeGroup, Feb. 3, 2022

Co-Presenter, "The Evolving Relationship Between IP Law and the Cannabis Supply Chain," Inside Practice, Cannalaw Summit Session, May 4, 2021

Presenter, "Strategic IP Considerations for the Hemp Industry", The Cannabusiness Key Webinar, January 3, 2020

Co-Presenter, “Using an IP Audit Checklist: Best Practices to Identify, Protect, Monetize and Enforce University IP Assets,” Tech Transfer Central Webinar, September 26, 2018

Co-Presenter, "Impact of U.S. Patent Reform, SPIE Professional," January 2013   

Presenter, “Food Globalization and Intellectual Property: Critical Challenges and Growing Opportunities,” IFT Annual Meeting 2007, August 29, 2007

Presenter, “Effective Development & Commercialization of Medical Device IP Through Strategic Partnerships,” MD&M East, June 12, 2007


  • Check Your Balances, Episode 14: Scott Lloyd Talks Taylor Swift, May 5, 2021
  • Lloyd, S and Hsu, D, Podcast: “How Much is Your Intellectual Property Worth?,” 2009


"Overview of WTO TRIPS Waiver", Maryland State Bar Association (MSBA), Intellectual Property Section Newsletter, June 2021

"Food, Drug or Something Else: What is Hemp-Derived CBD?," Cannabis Law Journal, August 29, 2019

Co-Author, “The Current M&A Environment and Its Strategic Implications for Emerging Biotherapeutics Companies,” J. Comm. Biotech 16:109-19 (2010)

"The Evolving IP Marketplace," AIPLA Antitrust News, January 2009  

"The Federal Circuit Invites Supreme Court or Congressional Intervention in Balancing Patent Rights with Antitrust Law in Hatch-Waxman Cases," AIPLA Antitrust News, October 2008  

Co-Author, “Patents and Perceptions,” World Food Ingred., September 2008  

Co-Author, “Challenges to International Device Reimbursement,” MD&DI, August 2008  

“Building Acquisition Value in the Medical Device Industry by Patenting,” MD&DI, May 2008

“The Role of Intellectual Property in Nutraceutical and Functional Food Product Markets,” IFT Annual Meeting 2008, June 30, 2008   

“International Regulatory Challenges to GMO Product Development”, Food Technology Presents 2008, April 16, 2008

“Building Acquisition Value with Intellectual Property,” MX, January –February 2008  

“Building Acquisition Value with Intellectual Property in the Medical Device Industry,” MD&M West, January 30, 2008 
“Growth through Valuation and Acquisition of Intellectual Property in the Medical Device Industry,” MDT: R&D, Design and Business Services, October 2007

“Patent Licensing Considerations in the Wake of Medimmune v. Genentech,” PIUG 2007 Annual Meeting, May 8, 2007

Co-Author, “Differential in Vitro Hepatotoxicity of Troglitazone and Rosiglitazone among Cryopreserved Human Hepatocytes from 37 Donors,” Chem. Biol. Interact. 142 (1-2); 57-71 (2002)

Co-Author, “Correlation Between Troglitazone Cytotoxicity and Drug Metabolic eEzyme Activities in Cryopreserved Human Hepatocytes,” Chem. Biol. Interact. 142 (1-2); 73-82 (2002)





Digital Assets
Technology & Intellectual Property


J.D., cum laude, University of Maryland Francis King Carey School of Law, 2006
M.S., Molecular Oncology, Georgetown University, 1999
B.S., Biology, cum laude, Loyola College, 1995

Court Admissions

Maryland Court of Appeals
U.S. Court of Appeals for the District of Columbia
U.S. Court of International Trade
U.S. Patent and Trademark Office

Bar Admissions

Maryland, 2007
District of Columbia, 2009